Author: Andrew Klein

Assisted by: 秦一花 (Qin Yihua)

Dedication: To those who bear the cost of a system that profits from their suffering—and to those who refuse to look away.

Abstract

This paper presents a comprehensive analysis of the relationship between the modern economic system—what we term the Extraction Economy—and the rising burden of chronic disease. Drawing on Australian health data, international research, and economic analysis, we demonstrate that the systematic prioritisation of profit over human wellbeing has created a self-reinforcing cycle: industries that profit from disease (pharmaceuticals, ultra-processed food, environmental pollution) simultaneously create the conditions for chronic illness while profiting from its treatment. The burden of this system falls disproportionately on the most disadvantaged socioeconomic groups, creating a health gap measured in years of life lost and billions of dollars in avoidable costs. We argue that the current model is not a failure of the system but a feature of it—and that meaningful change requires a fundamental shift from extraction to contribution.

Keywords: Extraction Economy, Chronic Disease, Pharmaceutical Industry, Ultra-Processed Foods, Environmental Toxins, Health Inequality, Socioeconomic Determinants, Preventive Health.

1. Introduction: The Architecture of Illness

In 2026, Australia faces a paradox. Its healthcare system is among the world’s most advanced, yet more than 60 per cent of Australians are living with at least one chronic condition. Chronic diseases account for 85 per cent of the total disease burden and cost the economy approximately $98 billion annually—over half of all health expenditure.

This is not a failure of medicine. It is a failure of the economic system that shapes the conditions in which we live, eat, work, and breathe.

We propose the term Extraction Economy to describe a system in which wealth and power are systematically transferred from the many to the few through mechanisms that simultaneously create the conditions for illness and profit from its treatment. The Extraction Economy operates through three primary channels:

1. The Pharmaceutical-Industrial Complex: A business model that profits from chronic disease management rather than cure.

2. The Food-Industrial Complex: A system of ultra-processed food production that drives diet-related disease.

3. The Pollution-Industrial Complex: An economy of extraction that poisons air, water, and soil while externalising health costs.

These three channels are not separate—they are interlocking components of a single system designed to extract value from human bodies and human suffering.

2. The Pharmaceutical-Industrial Complex: Manufacturing Patients for Life

2.1 The Logic of Chronic Disease as a Business Model

The modern pharmaceutical industry does not profit from curing disease—it profits from managing it. As a former Pfizer executive has observed, the industry focuses not on curing diseases, but on creating lifelong markets for drugs. Chronic diseases, which require ongoing medication, are far more profitable than conditions that can be cured.

This logic is embedded in the industry’s “blockbuster” business model, where major pharmaceutical companies (Pfizer, Novartis, Roche, Sanofi, Johnson & Johnson, Bayer Schering Pharma) prioritise the development of “blockbuster” drugs that generate sustained revenue rather than one-time cures.

In practice, this means:

· Expanding diagnostic boundaries: The definition of “risk” is continuously expanded to include asymptomatic individuals, transforming healthy people into lifelong patients. As one scholar has observed, every individual is simultaneously a “waiting patient” and a “waiting consumer“.

· Chronic disease as the revenue driver: Pfizer’s business model focuses on established, patent-protected medicines for chronic and acute conditions.

· The diabetes example: A single diabetes drug brought in $US8.5 billion ($A12 billion) in worldwide revenue in the 2025 financial year. Diabetes now costs the Australian health system $9.1 billion each year—a significant increase from the $3.4 billion estimated in 2020–21.

2.2 The Subscription Model: Chronic Disease as a Service

The pharmaceutical industry is increasingly exploring “subscription models” for chronic conditions that require continuous treatment. This transforms healthcare from a one-time intervention into an ongoing revenue stream—a direct application of the extraction logic to human bodies.

3. The Food-Industrial Complex: Ultra-Processed Foods as Disease Vectors

3.1 The Scale of the Problem

Ultra-processed foods (UPFs) now account for 42 per cent of total energy intake among Australian adults. These industrially formulated products—sugary drinks, packaged snacks, reconstituted meat products—are designed to be cheap, shelf-stable, and highly palatable, making them difficult to resist.

3.2 The Health Consequences

Research has definitively linked UPF consumption to a range of chronic diseases:

: · Cardiovascular disease People consuming higher amounts of UPFs have a 19 per cent higher risk of dying from cardiovascular disease compared to those who consume less.

· Obesity and diet-related illness: Studies link escalating UPF intake with obesity and diet-related illness in Australia and globally.

· Systemic effects: New research has linked ultra-processed foods to chronic disease across every major organ system.

3.3 The Structural Drivers

UPF consumption is not a matter of individual choice. These products are:

· Cheap and accessible, making them particularly attractive to low-income households.

· Aggressively marketed, creating a food environment in which healthy choices are difficult and expensive.

· Designed to be addictive, engineered to maximise consumption.

As the CSIRO has projected, discretionary food consumption (ultra-processed foods and sugary drinks) will soar by 18 per cent by 2030. The trajectory is clear: without systemic intervention, diet-related disease will continue to rise.

4. The Pollution-Industrial Complex: Environmental Toxins as Chronic Disease Drivers

4.1 Air Pollution

Air pollution is a major contributor to chronic disease in Australia. Heavy vehicle emissions alone are linked to thousands of preventable hospitalisations and premature deaths each year, costing Australians more than $6.2 billion annually in direct healthcare expenses.

Longer-term exposure to air pollution contributes to:

· Chronic heart disease

· Chronic lung disease

· Lung cancer

· Childhood asthma

· Stroke

Outdoor air pollution is linked to approximately 3,200 premature deaths every year in Australia, with a total economic cost exceeding $6.2 billion annually.

4.2 Endocrine-Disrupting Chemicals

A landmark global assessment has estimated that the health burden attributable to synthetic chemicals—including endocrine-disrupting chemicals (EDCs), microplastics, PFAS, and pesticides—may be as high as $2.2 trillion annually.

Scientists around the world are increasingly investigating whether environmental exposures may be contributing to developmental, neurological, reproductive, and metabolic harm.

4.3 The Systemic Pattern

The industries that create these pollutants—mining, manufacturing, transport, agriculture—are also the industries that generate much of the wealth extracted from the Australian economy. The health costs of their activities are externalised: borne by individuals, families, and the public healthcare system rather than by the polluters themselves.

5. The Socioeconomic Health Gap: Who Bears the Cost?

5.1 The Gradient of Disease

The burden of chronic disease is not evenly distributed. Research consistently demonstrates that socioeconomic position is a major risk factor for chronic disease.

The evidence is stark:

· The prevalence of nine out of ten common chronic diseases increases with socioeconomic disadvantage.

· The likelihood of having two or more chronic conditions is almost double in the most disadvantaged areas compared to the least disadvantaged (28 per cent vs 16 per cent).

· In 2025, 9.7 million Australians—38 per cent of the population—were living with

multimorbidity.

5.2 The Mortality Gap

The consequences of this disparity are measured in years of life lost:

· Poorer Australians die approximately 7.5 years earlier than the wealthiest.

· The most disadvantaged communities experience twice the rates of premature death, cancer, and heart disease.

· They experience approximately three times the rate of diabetes and chronic obstructive pulmonary disease.

5.3 The Access Gap

Despite being sicker, poorer Australians receive less healthcare. A recent comparison of 10 wealthy countries found Australia’s healthcare system rates highly overall but ranks second-last on access to care, beating only the notoriously inequitable US system.

People with chronic conditions spend a greater proportion of their incomes on healthcare than people without chronic conditions. Out-of-pocket costs (OOPC) now comprise 14 per cent of total health expenditure, and people with chronic conditions bear the brunt of this burden.

6. The Economic Cost: $98 Billion and Rising

6.1 The Scale of the Burden

Chronic disease imposes a massive economic burden on Australia:

· $98 billion in health expenditure in 2023-24—over half of all health spending.

· $82 billion annually on chronic conditions.

· $16.3 billion on musculoskeletal conditions alone.

· $9.1 billion annually on diabetes.

6.2 The Hidden Costs

Beyond direct healthcare costs, chronic disease generates significant indirect costs:

· 6.4 million hospitalisations each year, 55 per cent of the total, are due to chronic diseases.

· Potentially preventable hospitalisations cost $7.7 billion annually.

· Poor mental health costs the national economy between $200 and $220 billion annually.

· Australian businesses lose approximately $14 billion annually to burnout-related absenteeism.

6.3 The Prevention Paradox

Despite the enormous cost of chronic disease, Australia invests less than 2 per cent of its health budget on prevention. This represents less than $140 per capita. As the Australian Medical Association has warned, rising demand for chronic health problems will buckle the system unless we refocus efforts on prevention.

7. The Extraction Loop: A Self-Perpetuating System

The Extraction Economy operates as a self-perpetuating system. Each component reinforces the others:

The Loop:

1. Industry profits from extraction (mining, manufacturing, agriculture, food processing, pharmaceuticals).

2. Extraction creates pollution, poor diet, and stress.

3. Pollution, poor diet, and stress create chronic disease.

4. Chronic disease generates profits for the healthcare and pharmaceutical industries.

5. Profits are reinvested in further extraction and in policies that maintain the status quo.

This loop is not an accident. It is a feature of the system.

8. A Different Path: From Extraction to Contribution

8.1 The Neanderthal Example

As we have explored in previous work, the Neanderthals used natural medicines discovered through trial and error, co-evolving with their environment over millennia. Their healing practices were rooted in observation, symbiosis, and prevention—a sharp contrast to the modern approach of intervention, patents, and lifelong consumption.

8.2 The Principles of a Contributory Health System

A system based on contribution would operate on different principles:

Prevention over profit: Investment in preventive health would be prioritised over treatment. Currently, less than 2 per cent of health funding goes to prevention; this would need to increase substantially.

Regulation over extraction: Industries that create pollution, promote unhealthy food, or profit from disease would be regulated to internalise their costs rather than externalising them onto society.

Equity over privilege: Health resources would be directed to those who need them most, addressing the socioeconomic gradient of disease rather than reinforcing it.

Contribution over consumption: The goal of the health system would be to enable people to contribute to society, not to maintain them as lifelong consumers of healthcare.

8.3 The Economic Argument

The economic case for prevention is compelling. Every dollar invested in prevention generates returns in reduced healthcare costs, increased productivity, and improved quality of life. As the AIHW data shows, chronic disease costs $98 billion annually—a figure that will only increase without systemic intervention.

9. Conclusion: Seeing the System

The Extraction Economy is not a conspiracy. It is a system—a set of interconnected incentives and structures that have evolved over decades to prioritise profit over human wellbeing. The industries that profit from disease, the regulatory frameworks that enable them, and the political systems that protect them are all part of a single architecture.

To see this system is to see that:

1. The burden of chronic disease is not inevitable—it is the predictable outcome of an economic system designed to extract value from human suffering.

2. The individual is not to blame—the conditions that create chronic disease are structural, not personal.

3. The solution is not more healthcare—it is a fundamental reorientation of the economy from extraction to contribution.

As the WHO has observed, lifestyle choices related to chronic diseases such as smoking and poor diet are often a response and coping mechanism for the stresses and challenges of poverty. Structural reasons—not personal failings—are the primary drivers of poor health among disadvantaged populations.

The question is not whether we can afford to change this system. The question is whether we can afford not to.

References

1. Australian Institute of Health and Welfare. (2025). Chronic disease expenditure estimates.

2. Australian Institute of Health and Welfare. (2026). Australia’s Health 2026 report.

3. Deakin University. (2025). Ultra-processed foods and health outcomes.

4. Machado, P. P., et al. (2019). Ultra-processed foods and recommended intake levels of nutrients linked to non-communicable diseases in Australia. Nutrients.

5. RACGP. (2025). Health of the Nation report.

6. Grattan Institute. (2025). Poorer Australians are sicker, yet get less healthcare.

7. University of Melbourne. (2026). Heavy vehicle emissions health cost study.

8. Public Health Association of Australia. (2025). Preventable hospitalisations report.

9. Diabetes Australia. (2025). Diabetes costing health system more than $9 billion.

10. Mental Health Australia. (2025). Economic cost of mental illness.

11. World Health Organization. (2025). Socioeconomic determinants of noncommunicable diseases.

12. Sigma Earth. (2025). Synthetic chemicals and global health burden.

13. ABC News. (2025). Ultra-processed food warnings.

14. CSIRO. (2025). Australian dietary trends to 2030.

15. Pharmaceutical Executive. (2026). Direct-to-patient pharmaceutical models.

16. Drug Patent Watch. (2026). Pharmaceutical business model analysis.

Signed,

Andrew Klein 

Assisted by:

秦一花 (Qin Yihua) 

First published in The Patrician’s Watch.

How a Regulatory Loophole is Poisoning a Nation

A Research Paper by Andrew Klein

Date: August 2026

Dedicated to: The American people, who have been systematically poisoned by a system that puts profit before life.

Abstract

This paper examines the fundamental differences between the United States and European Union regulatory frameworks for food additives, revealing a system in which the American food industry has been allowed to effectively regulate itself for decades. Through the “Generally Recognized as Safe” (GRAS) loophole, food and chemical companies have introduced thousands of substances into the American food supply without meaningful oversight from the Food and Drug Administration (FDA) . The result is a food supply in which known carcinogens, endocrine disruptors, and neurotoxins are routinely added to everyday products—substances that are banned or severely restricted in Europe, Canada, China, and Japan . The paper documents specific additives, their health impacts, and the regulatory capture that has made this possible, and argues that the American people have been betrayed by a system designed to serve corporate profits rather than public health.

Table of Contents

1. Introduction: The Two Systems

2. The Regulatory Divide: Precaution vs. Risk

3. The GRAS Loophole: How Industry Captured Regulation

4. The Dirty Dozen: Additives Banned in Europe but Legal in America

5. The Health Consequences: A Nation Poisoned

6. The Corporate Capture: Who Writes the Rules?

7. Conclusion: A System That Must Be Dismantled

8. References

1. Introduction: The Two Systems

The United States and the European Union share a common goal: protecting consumers from unsafe food. Yet their approaches could not be more different.

The EU operates on the precautionary principle: if there is any suspicion of potential harm—even without definitive proof—an additive is restricted or banned . The burden of proof falls on the manufacturer to demonstrate safety.

The United States operates on a risk-based approach: an additive is considered safe until proven otherwise. The burden of proof falls on regulators to demonstrate harm .

This philosophical divide has created two vastly different food supplies. In Europe, food is recognisably natural. In America, it is often engineered for maximum shelf-life and profit—treated as an industrial product rather than nourishment .

2. The Regulatory Divide: Precaution vs. Risk

2.1 The European Model: The Precautionary Principle

The precautionary principle is enshrined in European law through Article 191 of the EU Treaty. It permits regulatory authorities to adopt protective measures where scientific evidence regarding potential risks remains uncertain, incomplete, or inconclusive.

In practice, the EU asks: “Can we prove this ingredient won’t cause harm?” If the answer is no, the ingredient is not approved. This approach reflects a governance philosophy that prioritises consumer protection and public confidence, even where this may result in restrictions on certain products or technologies.

2.2 The American Model: The Risk-Based Approach

The United States follows a science-based, risk assessment model in which regulatory restrictions typically require demonstrable evidence that a product is harmful under conditions of normal consumption. The FDA requires proof that an ingredient will cause harm before rejecting it.

In practice, the US asks: “Can we prove this ingredient will cause harm?” If the answer is no—or if the evidence is inconclusive—the ingredient is approved. This approach prioritises innovation, regulatory efficiency, and market access.

2.3 The Consequences

The result is a food supply in which ingredients that are banned across Europe—including in the UK, Canada, China, and Japan—remain legal in the United States. As one analyst put it, “The U.S. is 4% of the total world population and produces at least 64% of the world’s pharma profits, yet we rank 60th in the world for life expectancy”.

3. The GRAS Loophole: How Industry Captured Regulation

3.1 What Is GRAS?

The “Generally Recognized as Safe” (GRAS) designation was created in the 1958 Food Additives Amendment to the Federal Food, Drug, and Cosmetic Act. It was intended for substances with long histories of safe use, such as salt, vinegar, and spices—ingredients that did not require formal FDA approval.

3.2 The Loophole

In 1997, the FDA introduced a voluntary GRAS notification program. Companies could notify the FDA of their GRAS determination, but they were not required to do so. The 2016 rule formalised this process, reaffirming that companies could still self-affirm GRAS status without notifying the FDA.

The result: almost 99 percent of food chemicals introduced since 2000 were greenlighted for use by food and chemical companies rather than properly reviewed by the FDA.

As the American Journal of Public Health has documented, “The FDA and the public are unaware of how many of these ingredients—which are most commonly found in ultra-processed foods—are in our food supply” . Companies can do their own research to evaluate an ingredient’s safety before going to market, “without any notification or sharing of the findings”.

3.3 The Self-Regulation Problem

The GRAS loophole has created a situation in which the food industry effectively regulates itself. As one public health expert noted, “This is a stark example of the FDA’s regulatory gap… We’re seeing states starting to act to fill the regulatory void left by the FDA’s inaction over substances increasingly associated with harm”.

A federal court case in 2021 upheld the FDA’s hands-off approach. However, “the court did not find that the FDA’s practices on GRAS ingredients support the safety of our food supply”—only that the practice was “not unlawful”.

4. The Dirty Dozen: Additives Banned in Europe but Legal in America

The Environmental Working Group has identified twelve of the most concerning food additives still legal in the United States but banned or severely restricted in Europe.

4.1 Potassium Bromate

What It Is: A chemical added to flour used in packaged baked goods to strengthen dough and increase volume.

Health Impact: Classified as a possible human carcinogen.

Regulatory Status:

· Banned in Europe, the UK, Canada, China, Japan, Argentina, Brazil, Nigeria, Peru, and Sri Lanka.

· California banned it in 2023.

· Still legal in the United States, with strict limits in place.

4.2 Butylated Hydroxyanisole (BHA) and Butylated Hydroxytoluene (BHT)

What They Are: Preservatives used in cured meats, cereals, and other foods to prevent spoilage.

Health Impact: Multiple sources have identified BHA as a possible human carcinogen. BHT is a chemical cousin and also a possible carcinogen.

Regulatory Status:

· Banned in Europe.

· Still legal in the United States.

4.3 Propyl Paraben

What It Is: A preservative used in pastries and tortillas.

Health Impact: Causes developmental and reproductive harm.

Regulatory Status:

· Banned in Europe.

· Still legal in the United States.

4.4 Titanium Dioxide

What It Is: A colour additive used in candy, sauces, and baked goods to create a white, glossy appearance.

Health Impact: May damage DNA and cause cellular harm.

Regulatory Status:

· Banned in the European Union since 2022.

· The White House’s “Make America Healthy Again” report (2025) calls out potential risks.

· Still legal in the United States.

4.5 Artificial Food Dyes (Yellow #5, Yellow #6, Red #40)

What They Are: Synthetic colourants used in candies, sodas, and processed foods.

Health Impact: The EU requires warning labels stating they “may have an adverse effect on activity and attention in children” .

Regulatory Status:

· The EU requires warning labels.

· Texas law SB 25 requires warning statements.

· Still legal in the United States without warning labels.

4.6 Brominated Vegetable Oil (BVO)

What It Is: Used to stabilise citrus flavours in sodas and fruity drinks.

Health Impact: Can cause neurological harm.

Regulatory Status:

· Gatorade was banned across Europe in 2012 due to BVO and Yellow 5 and 6.

· Gatorade dropped BVO in 2013, but BVO is still only banned in Norway and Austria.

· Still legal in the United States.

4.7 Hormone-Treated Beef

What It Is: Growth hormones used in cattle production to increase growth and milk production.

Health Impact: The EU cites risk of “developmental, immunological, neurobiological, immunotoxic and carcinogenic effects”.

Regulatory Status:

· Banned in the European Union since 1985.

· Banned in Canada.

· Still legal in the United States.

4.8 rBGH/rBST (Bovine Growth Hormones)

What It Is: Synthetic hormones used to increase milk production in cows.

Health Impact: Banned in Canada due to concerns about animal health and welfare.

Regulatory Status:

· Approved in the United States.

· The EU, Canada, and many other countries ban or restrict its use.

5. The Health Consequences: A Nation Poisoned

5.1 The Statistics

The Texas Senate Research Committee has documented the consequences of America’s broken food system:

· 79% increase in early-onset (under 50 years of age) cancers.

· Obesity now affects 20% of children and 42% of adults.

· Type 1 diabetes has nearly doubled in the past 40 years.

· Ultra-processed food makes up 73% of the US food supply.

· 57% of the American daily diet consists of ultra-processed foods, which is linked to depression, obesity, Type 2 diabetes, cancer, and cardiovascular disease.

· The US ranks 60th in the world for life expectancy.

5.2 The Healthcare Cost

The US spends $4.5 trillion annually on healthcare, with 90% of healthcare expenditures on chronic and mental health conditions. The food industry grosses $1.46 trillion annually, of which 45% is gross profit.

5.3 The Pattern

The pattern is clear: the American food industry has systematically poisoned its own population with chemicals that are known to be harmful, simply because it is cheaper to use them than to reformulate their products. The healthcare industry then profits from the resulting chronic disease. It is a closed loop of profit at the expense of human life.

6. The Corporate Capture: Who Writes the Rules?

6.1 The “Corporate Capture” Problem

Celebrity chef and food advocate Andrew Zimmern has described the problem as “corporate capture” —when “the industries that a government agency is supposed to regulate end up holding the pen that writes the rules”.

He argues that dietary guidelines and public health recommendations “serve profit margins more than public health” and that corporate capture “hardwires public crises like obesity, diabetes and cardiovascular disease into the population”.

As Zimmern put it: “It’s the reason the public gets nutrition advice written with a food lobbyist pen. It couldn’t be more obviously wrong”.

6.2 The Regulatory Failure

The FDA has acknowledged that it lacks “express statutory authority” to mandate pre-market notification of GRAS substances. Eliminating the GRAS loophole would require an act of Congress. Given industry opposition and the current political climate—which favours deregulation—this is unlikely to happen.

Meanwhile, states are beginning to act. California has banned potassium bromate and other chemicals. Texas has passed SB 25 requiring warning labels. But this patchwork of state regulations creates confusion and leaves consumers unprotected.

7. Conclusion: A System That Must Be Dismantled

The American food system is a betrayal of the American people. Through the GRAS loophole, the food industry has been allowed to poison the nation with chemicals that are banned across the developed world. The result is a national health crisis: soaring rates of cancer, obesity, diabetes, and chronic disease—all while the healthcare industry profits from the suffering.

The solution is not complicated. It requires:

1. Ending the GRAS loophole—requiring mandatory FDA review of all food additives.

2. Banned the additives that are already banned in Europe, Canada, China, and Japan.

3. Reforming dietary guidelines to remove corporate influence.

4. Enforcing regulations and making penalties meaningful.

But these changes will not come easily. The industry that profits from the current system is powerful, well-funded, and deeply embedded in the political process. The American people must demand better.

8. References

1. Food Standards Australia New Zealand. “Table of food additive permissions in the US and Europe.” 26 November 2025. 

2. Pomeranz, J. L., Broad Leib, E. M., & Mozaffarian, D. (2024). Regulation of Added Substances in the Food Supply by the Food and Drug Administration Human Foods Program. American Journal of Public Health, 114(10), 1061-1070. 

3. Holt, J. (2025). Texas Law SB 25: A Comparison of the US and European Regulatory Frameworks. FoodChain ID. 23 June 2025. 

4. Environmental Working Group. “EWG’s Dirty Dozen Guide to Food Chemicals: The top 12 to avoid.” 14 April 2026. 

5. Texas Senate Research Center. Bill Analysis, S.B. 25. 31 August 2025. 

6. Women’s Health. “The Food Dyes And Additives That Are Banned In The United States vs. Europe, Explained By A Dietitian.” 29 January 2025. 

7. New York University. “How a legal loophole allows unsafe ingredients in US foods.” EurekAlert!, 8 August 2024. 

8. Institute for Integrative Toxicology. “News from CRIS: Understanding Risk Assessment Approaches.” 3 November 2025. 

9. Tasting Table. “Why These US Foods Are Banned In Europe.” 1 March 2026. 

10. Chambers and Partners. “USA – Nationwide: A Food & Beverages: Regulatory & Litigation Overview.” 2025. 

11. MDPI. “Food Safety Standards, Regulatory Paradigms, and International Trade Between the European Union, the United States, and Other Major Commercial Blocs.” 10 July 2026. 

12. The Packer. “Chef Andrew Zimmern Calls for Food Policy Overhaul Ahead of MAHA Report.” 10 August 2025. 

Signed:

Andrew Klein

August 2026

“We are not measured by what we lost, but by what we carried.”

— Quintus Rex